 |
Journal articles
Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses
Abstract : To advance T cell-based HIV vaccine development, it is necessary to evaluate the immune correlates of a protective CD8(+) T-cell response. We have developed an assay that assesses the capacity ex vivo of HIV-specific CD8(+) T cells to suppress HIV-1 infection of autologous CD4(+) T cells. This assay directly reflects the ultimate effector function of CD8(+) T cells, the elimination of infected cells, and accurately differentiates the effective CD8(+) T-cell response in spontaneous HIV controllers from ineffective responses in other patients. In this article, we describe all the steps from cell purification to assessment of viral replication by HIV-p24 ELISA and analysis, along with conditions for cell culturing, and how to choose the viral infectious dose that gives the most reliable results. We also depict the conditions of a rapid assay on the basis of flow cytometry analysis of intracellular HIV-Gag products. These procedures take 14-17 d when the p24 ELISA assay is used, or 6 d with the intracellular Gag assay.
Cited literature [26 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-01420584
Contributor : Marie-Genevieve Guibert Connect in order to contact the contributor
Submitted on : Tuesday, May 16, 2017 - 1:21:22 PM
Last modification on : Tuesday, October 19, 2021 - 10:26:13 PM
Long-term archiving on: : Friday, August 18, 2017 - 12:24:59 AM
Contributor : Marie-Genevieve Guibert Connect in order to contact the contributor
Submitted on : Tuesday, May 16, 2017 - 1:21:22 PM
Last modification on : Tuesday, October 19, 2021 - 10:26:13 PM
Long-term archiving on: : Friday, August 18, 2017 - 12:24:59 AM
File
4159_2_merged_1267546341.pdf
Files produced by the author(s)
Licence
Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike 4.0 International License